DRTG(SH:600329) Tong Hua Shun Cai Bao·2025-03-30 07:57Financial Performance - The company reported a basic earnings per share of 2.90 yuan for 2024, a significant increase of 126.56% compared to 1.28 yuan in 2023 [1] - Net profit for 2024 reached 22.29 billion yuan, up 125.84% from 9.87 billion yuan in the previous year [1] - Operating revenue decreased to 73.07 billion yuan, down 11.13% from 82.22 billion yuan in 2023 [1] - The return on equity (ROE) improved to 30.51%, a 102.59% increase from 15.06% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 48,220.72 million shares, accounting for 62.86% of the circulating shares, with a decrease of 416.32 million shares compared to the previous period [1] - Tianjin Pharmaceutical Group Co., Ltd. remains the largest shareholder with 33,112.05 million shares, representing 43.17% of total share capital [2] - ABN AMRO CLEARING BANK N.V. increased its holdings by 37.12 million shares, now holding 7,324.99 million shares, which is 9.55% of total share capital [2] Dividend Distribution - The company announced a dividend distribution plan of 10 shares for every 12.8 yuan (including tax) [2]